QC
ONC

Quadrature Capital’s BeOne Medicines Ltd ONC Stock Holding History

Quadrature Capital’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.32M Buy
+29,203
New +$8.61M 0.07% 207
2026
Q1 		– Sell
-11,334
Closed -$3.44M – 1969
2025
Q4 		$3.44M Buy
+11,334
New +$3.71M 0.04% 275

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Quadrature Capital's ONC Position: Q2 2026 in Review

Quadrature Capital opened a new position in BeOne Medicines Ltd (ONC) in Q2 2026: 29,203 shares worth $8.32M. The stake represents 0.07% of the portfolio and ranks #207 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in ONC as recently as Q4 2025.

Quadrature Capital first reported a position in ONC in Q4 2025 and has held it in 2 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Quadrature Capital held 29,203 shares of BeOne Medicines Ltd worth $8.32M as of Q2 2026.
  • BeOne Medicines Ltd was a new Quadrature Capital position in Q2 2026.
  • BeOne Medicines Ltd made up 0.07% of Quadrature Capital's portfolio in Q2 2026, its #207 holding.
  • Quadrature Capital first reported a position in BeOne Medicines Ltd in Q4 2025 and has held it in 2 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.